Education and training in adult metabolic medicine: Results of an international survey.

adult metabolic medicine education and training inherited metabolic diseases survey

Journal

JIMD reports
ISSN: 2192-8304
Titre abrégé: JIMD Rep
Pays: United States
ID NLM: 101568557

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 12 02 2019
revised: 06 05 2019
accepted: 06 05 2019
entrez: 10 9 2019
pubmed: 10 9 2019
medline: 10 9 2019
Statut: epublish

Résumé

Adult metabolic medicine (AMM) is an expanding medical subspecialty, due to the increasing number of adult patients with inherited metabolic diseases (IMD). However, a formal training and postgraduate education in this field is not available in the majority of countries. Existing adult metabolic specialists (AMS) come from many different backgrounds. The aim of this survey was to assess the state of play as regards education and training in AMM worldwide. Members of the Society for the Study of Inborn Error of Metabolism adult metabolic group (n = 89) were asked to take part in this survey. Forty-two AMS (47.2%) from 18 different countries completed the questionnaire. The most common specialties were internal medicine (38.1%), endocrinology (26.2%), genetics (21.4%), and neurology (21.4%). Ninety-five percent of respondents considered that practical clinical experience had contributed importantly for their professional development, while only 27% felt the same for formal academic education. The current state of available education and training was judged as generally poor or fair (73% of the respondents). The most suggested ways of improving education and training in AMM were: to facilitate international internships; to implement courses on adult-IMD; and to create a formal academic education. The skills considered most important for AMS were: recognition of signs and symptoms of diseases, knowledge of the available treatments, and ability to perform a correct follow up. In conclusion, worldwide, current available education and training in AMM is considered inadequate. This survey emphasizes the need for development of new, formal training opportunities to improve knowledge, and competence in this rapidly expanding field.

Identifiants

pubmed: 31497483
doi: 10.1002/jmd2.12044
pii: JMD212044
pmc: PMC6718119
doi:

Types de publication

Journal Article

Langues

eng

Pagination

63-69

Déclaration de conflit d'intérêts

Annalisa Sechi, Elisa Fabbro, Mirjam Langeveld, Robin Lachmann, and Fanny Mochel declare that they have no conflict of interest.

Références

JIMD Rep. 2019 Jun 21;49(1):63-69
pubmed: 31497483
J Inherit Metab Dis. 2018 Sep;41(5):765-776
pubmed: 29335813
JIMD Rep. 2016;27:85-91
pubmed: 26450566
J Inherit Metab Dis. 2002 May;25(3):252-60
pubmed: 12137234
J Hosp Infect. 2015 Apr;89(4):351-6
pubmed: 25777079
J Inherit Metab Dis. 2018 Sep;41(5):753-756
pubmed: 29876767
Ned Tijdschr Geneeskd. 2014;158:A7745
pubmed: 25096043

Auteurs

Annalisa Sechi (A)

Regional Coordinator Centre for Rare Diseases Academic Hospital of Udine Udine Italy.

Elisa Fabbro (E)

Department of Medicine University of Udine Udine Italy.

Mirjam Langeveld (M)

Academic Medical Centre University of Amsterdam Amsterdam The Netherlands.

Annarita Tullio (A)

Institute of Hygiene and Clinical Epidemiology Academic Hospital of Udine Udine Italy.

Robin Lachmann (R)

Charles Dent Metabolic Unit, NHNN London UK.

Fanny Mochel (F)

Reference Center for Neurometabolic Diseases La Pitié-Salpêtriere University Hospital Paris France.

Classifications MeSH